Ip Pharmaceuticals India Private Limited
About Ip Pharmaceuticals India Private Limited
Data last updated:
Ip Pharmaceuticals India Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Inno Pharma Inc. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the hospital infrastructure and equipment providers segment of the healthcare sector. It was incorporated on 20 January 2011.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2011PTC290919. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Ketan Bhupendra Palan and Prajeet Nair.
Its last annual general meeting (AGM) was held on 09 July 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at The Capital 1802/1901 Plot No. C – 70 G Block Bandra Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051.
As per the financials filed for FY 2021, the company reported a revenue of ₹8.49 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹4.99 Lakh (net margin 58.8%) and EBITDA of ₹6.67 Lakh (EBITDA margin 78.6%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 55% over five years.
Company details
CIN history
Ip Pharmaceuticals India has one previous CIN (Corporate Identification Number): U24239KA2011PTC056722. The current CIN is U24239MH2011PTC290919, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH2011PTC290919 | Current |
| U24239KA2011PTC056722 | Previous |
Contact details
Ip Pharmaceuticals India Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressThe Capital 1802/1901 Plot No. C – 70 G Block Bandra Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051
- IndustryHealthcare, Hospital Infrastructure & Equipment Providers
To see the full contact details of Ip Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Ip Pharmaceuticals India Private Limited
FY 2021 filings availableIp Pharmaceuticals India Private Limited reported revenue of ₹8.49 Lakh (down 16% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 55% over five years, including a 16% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.67 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 78.6% | ||||
| Net Profit Margin | 58.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ip Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Ip Pharmaceuticals India Private Limited
Ip Pharmaceuticals India has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ketan Bhupendra Palan | Director | 05 Mar 2020 | 6 Years 7 Months | As last reported |
| Prajeet Nair Also directs: Wyeth Pharmaceuticals India Private Limited | Director | 29 Jul 2015 | 11 Years 3 Months | As last reported |
Peer comparison
Ip Pharmaceuticals India Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Hospital Infrastructure, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cilead Pharmaceuticals Private Limited | ₹8.53 Lakh (FY 2025) | Jaipur, Rajasthan, India | ||||
| Astrova Pharmaceuticals Private Limited | ₹8.52 Lakh (FY 2023) | -91.0% | Thane, Maharashtra, India | |||
| Zrox Pharmaceuticals Private Limited | ₹8.51 Lakh (FY 2021) | -6.0% | Yamuna Nagar, Haryana, India | |||
| Nidedak Pharmaceuticals Private Limited | ₹8.51 Lakh (FY 2024) | -10.0% | Allahabad, Uttar Pradesh, India | |||
| Hyssop Pharmaceuticals Private Limited | ₹8.5 Lakh (FY 2024) | -55.0% | Ranchi, Jharkhand, India | |||
| Ip Pharmaceuticals India Private Limitedthis company | ₹8.49 Lakh (FY 2021) | ₹4.99 Lakh | 58.8% | -16.0% | Mumbai, Maharashtra, India | |
| Endospy Pharmaceuticals Private Limited | ₹8.48 Lakh (FY 2025) | 70.0% | Pune, Maharashtra, India | |||
| Trans Pharmaceuticals Private Limited | ₹8.48 Lakh (FY 2021) | -85.0% | Ahmednagar, Maharashtra, India | |||
| Wellborn Pharmaceuticals Private Limited | ₹8.44 Lakh (FY 2018) | -43.0% | New Delhi, Delhi, India | |||
| Kon Pharmaceuticals Trading Private Limited | ₹8.43 Lakh (FY 2025) | 13.0% | Burdwan, West Bengal, India | |||
| Vagmin Pharmaceuticals Private Limited | ₹8.43 Lakh (FY 2019) | Bangalore, Karnataka, India |
To see the full peer comparison of Ip Pharmaceuticals India Private Limited, buy the company report.
Auditor
Ip Pharmaceuticals India Private Limited is audited by H N S RAO & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H N S RAO & CO | FY 2017 | 003129S |
Shareholding
The shareholding of Ip Pharmaceuticals India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ip Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ip Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ip Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ip Pharmaceuticals India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ip Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Ip Pharmaceuticals India Private Limited has 9 board changes on record since 2015: 2 appointments and 7 cessations. The latest: Ketan Bhupendra Palan ceased to be Additional Director on 28 Sep 2020.
Frequently asked questions
Ip Pharmaceuticals India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Ip Pharmaceuticals India was a private limited company based in Mumbai, Maharashtra, India. The company worked in hospital infrastructure and equipment providers, within the healthcare industry. It was incorporated on 20 January 2011 and is registered under CIN U24239MH2011PTC290919. The company has been struck off by the Registrar of Companies and is no longer operational.
Ip Pharmaceuticals India had 2 directors:
- Ketan Bhupendra Palan - Director
- Prajeet Nair - Director
The CIN (Corporate Identification Number) of Ip Pharmaceuticals India is U24239MH2011PTC290919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ip Pharmaceuticals India is at The Capital 18021901 Plot No. C – 70 G Block Bandra Kurla Complex Bandra East, Mumbai, Maharashtra, India – 400051.
Ip Pharmaceuticals India was incorporated on 20 January 2011. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Ip Pharmaceuticals India on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 09 July 2021. Year-wise statements from 2015 are in the company report.
No. Ip Pharmaceuticals India has 1 GST registration on record and it is cancelled or inactive.
Ip Pharmaceuticals India operated in the healthcare industry, in the hospital infrastructure and equipment providers segment. It worked in this industry before it was struck off.
The peers of Ip Pharmaceuticals India by revenue are Cilead Pharmaceuticals Private Limited, Astrova Pharmaceuticals Private Limited, Zrox Pharmaceuticals Private Limited, Nidedak Pharmaceuticals Private Limited, Hyssop Pharmaceuticals Private Limited and 5 more, all in the Healthcare industry (Hospital Infrastructure, Pharmaceuticals).
Ketan Bhupendra Palan ceased to be Additional Director on 28 Sep 2020. Ketan Bhupendra Palan was appointed as Director on 05 Mar 2020. Samir Salauddin Kazi ceased to be Director on 05 Mar 2020. Ip Pharmaceuticals India has 9 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
